Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
including the chemo-resistant mouse pancreatic ductal carcinoma as well as the human prostate tumor model LNCaP
GSK2118436 is sufficient to reduce S6P phosphorylation in A375
These data suggest that direct inhibition of the oncogenic CBFβ-SMMHC fusion protein may be an effective therapeutic approach for inv(16) AML
It can serve as a very useful reagent to enhance the safety of hPSC-based treatments and facilitate safe transplantation of larger cell numbers
Mice treated with GSK2110183 at 10
WHI-P154 - CAS# 211555-04-3 Catalog No.:M6563-2 including the chemo-resistant mouse pancreaticWHI P154, CAS No. 211555 04 3, is a JAK3 inhibitor with IC50 = 1. 8 microM. WHI P154 displays no activity at JAK1 or JAK2. WHI P154 also Inhibits STAT1 activation, iNOS expression and NO production in macrophages in vitro . Also inhibits other common kinases including EGFR (IC50 = 4 nM), Src, Abl, VEGFR, MAPK and PI 3 K and induces apoptosis in human glioblastoma cell lines (IC50 = 158 microM). Product information CAS Number: 211555 04 3 Molecular
US$ 38.00
US$ 1640.00
US$ 389.70
US$ 579.21
US$ 174.99